// App-Quantinova.ai

: Comparative assessment of the performance of pharmacokinetic tools for prophylactic dosing of factor VIII concentrate in patients with hemophilia A

Researchers

Presenter

  • P. Staibano

Principal Investigators

  • A. McEnenyKing

  • M. Morfini

  • G. Foster

  • N. Hobson

  • T. NavarroRuan

  • A. N. Edginton

  • A. Iorio

Medical Centers

  • Faculty of Medicine, University of Ottawa, Canada

  • School of Pharmacy, University of Waterloo, Waterloo, ON, Canada

  • Associazione Italiana Centri Emofilia AICE, Firenze, Italy

  • Biostatistics Unit, St. Joseph's Healthcare, Hamilton, Canada

  • Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada

  • School of Pharmacy, University of Waterloo, Waterloo, ON, Canada

  • Health Reseach Methods, Evidence, and Impact, Hamilton, Canada

  • Department of Medicine, McMaster University, Hamilton, ON, Canada

Locations

  • Canada

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • FVIII

  • Advate

Outcome

  • N/A


Study Design

  • Pharmacokinetics

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A